Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,593.20
+753.73(+1.51%)

'We sold £1.5m of product sold in first week'

Lyma founder on rise of her wellness company

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.4500

-0.0300

(-2.03%)

At close: 04:00PM EDT

1.4000

-0.05

(-3.45%)

After hours:

07:30PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	199.50M
Enterprise value	48.78M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.34
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-1.01

Trading information

Stock price history

Beta (5Y monthly)	0.60
52-week change ³	-53.53%
S&P500 52-week change ³	22.36%
52-week high ³	3.6200
52-week low ³	1.1500
50-day moving average ³	1.8226
200-day moving average ³	1.9061

Share statistics

Avg vol (3-month) ³	375.31k
Avg vol (10-day) ³	229.59k
Shares outstanding ⁵	137.59M
Implied shares outstanding ⁶	137.59M
Float ⁸	102.85M
% held by insiders ¹	13.44%
% held by institutions ¹	62.89%
Shares short (15 Apr 2024) ⁴	1.62M
Short ratio (15 Apr 2024) ⁴	3.95
Short % of float (15 Apr 2024) ⁴	1.60%
Short % of shares outstanding (15 Apr 2024) ⁴	1.18%
Shares short (prior month 15 Mar 2024) ⁴	1.88M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-17.66%
Return on equity (ttm)	-25.74%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-49.66M
Net income avi to common (ttm)	-42.49M
Diluted EPS (ttm)	-0.3300
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	152.46M
Total cash per share (mrq)	1.11
Total debt (mrq)	1.73M
Total debt/equity (mrq)	1.17%
Current ratio (mrq)	19.73
Book value per share (mrq)	1.16

Cash flow statement

Operating cash flow (ttm)	-40.62M
Levered free cash flow (ttm)	-25.2M